Transforming Growth Factor- β-induced Cell Growth Inhibition in Human Breast Cancer Cells Is Mediated through Insulin-like Growth Factor-binding Protein-3 Action

This publication has 25 references indexed in Scilit:

• Insulin-like Growth Factor Binding Protein 3 (IGF-BP3) Inhibits Estrogen-Stimulated Breast Cancer Cell Proliferation
  Biochemical and Biophysical Research Communications, 1994
• Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptor
  Cell, 1993
• Inhibition of growth‐factor‐activated proliferation by anti‐estrogens and effects on early gene expression of mcf‐7 cells
  International Journal of Cancer, 1993
• Non-receptor mediated, post-transcriptional regulation of insulin-like growth factor binding protein (IGFBP)-3 in Hs578T human breast cancer cells
  Endocrinology, 1992
• Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid
  Journal of Clinical Endocrinology & Metabolism, 1992
• Insulin-like growth factor-I (IGF-I) and transforming growth factor- beta 1 release IGF-binding protein-3 from human fibroblasts by different mechanisms
  Endocrinology, 1992
• Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines
  Journal of Cellular Physiology, 1989
• Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
  Cell, 1987
• Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose
  Cell, 1986
• Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells
  Nature, 1985